Peptide therapy TikTok claims: separating hype from human data

What did @strongherself actually say?

Honestly? Not much. The transcript consists entirely of the phrase "add it to my car" repeated four times. There are no peptide claims here, no dosing recommendations, no mechanism of action explained, no before-and-after narrative. Whatever point this video was trying to make did not survive the transcription process, or it was a shopping-cart-style haul clip with no substantive health content attached.

That means there is nothing to directly quote in a meaningful scientific context. The creator may have been gesturing at products on screen, referencing a peptide stack, or simply creating an engagement-bait clip. Without visible product names or spoken claims, we are fact-checking a blank slate in the peptides category.

Does the science back this up?

There is no claim here to evaluate against the science. But since this video sits in the peptides category on a telehealth platform, it is worth addressing what the current evidence actually looks like for commonly discussed peptides, so viewers who landed here from a similar video have something useful to read.

BPC-157 has shown wound-healing and gut-protective effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but human randomized controlled trial data remains sparse. TB-500, or its active fragment thymosin beta-4, has similarly promising preclinical data on tissue repair (Goldstein and Kleinman, 2015, Annals of the New York Academy of Sciences) with limited human evidence. GHK-Cu has demonstrated skin-remodeling properties in vitro and in small trials (Pickart and Margolina, 2018, Biomolecules), but "anti-aging" claims routinely outpace the data. The pattern across nearly all these compounds is the same: interesting preclinical signals, weak or absent large-scale human trials.

What did they get wrong (or right)?

Impossible to say for this specific video. No claims were made, so no claims can be graded. That said, the framing of a peptide haul or wishlist carries its own implicit message: that these compounds are consumer products to be casually accumulated, like supplements off a grocery shelf. That framing is worth pushing back on.

These are largely unregulated, compounded, or research-grade substances. Many are not FDA-approved for human use. Some require refrigeration, sterile injection technique, and medical oversight to use responsibly. The "add it to my cart" framing, even if innocent, normalizes a level of casualness about compounds that carry real risks including injection site reactions, hormonal disruption with peptides like MK-677, and unknown long-term safety profiles across the board. MK-677, for instance, is not a peptide but a ghrelin mimetic, and it raises IGF-1 levels in ways that carry theoretical cancer-promotion concerns with extended use (Nass et al., 2008, Journal of Clinical Endocrinology and Metabolism).

What should you actually know?

If you are researching peptides because a TikTok video made them sound appealing, here is the honest version. Some of these compounds have genuinely interesting science behind them. BPC-157 and TB-500 are not snake oil. Researchers are studying them for real reasons. But interesting preclinical data is not the same as proven efficacy in humans, and the gap between those two things is where a lot of social media health content quietly disappears.

Before considering any peptide therapy, the relevant questions are: Is there human trial evidence for your specific goal? Is the source pharmaceutical-grade or compounded by a licensed pharmacy? Do you have a prescribing clinician who is monitoring relevant labs? The answer to all three should be yes. Peptides obtained without a prescription from grey-market sources carry contamination risks, mislabeling risks, and zero accountability if something goes wrong. A TikTok shopping cart is not a clinical protocol.

• Peptide therapy, when appropriate, should be supervised by a licensed provider with lab monitoring.
• Compounded peptides are not equivalent to any FDA-approved drug version of those compounds.
• No peptide on this list is approved to treat, cure, or prevent any disease in the United States.